Aktieanalys

Lifecare: Target for pilot production reached - Redeye

Redeye Publicerad: 03 Apr 08:59

Redeye views today's press release from Lifecare positively, announcing that it has reached the target for pilot production of the Sencell sensor. This milestone paves the way for automated production by the end of Q2, in line with the previously scheduled timeline. Automated large-volume production is a crucial aspect of the investment case in Lifecare, and today's confirmation further derisks the long-term outlook. We anticipate additional share price supporting developments in the coming months including the start of the LFC-SEN-002 trial in dogs, launch of veterinary product, and automated production. Our base case stands at NOK 4.5.

Länk till analysen i sin helhet: https://www.redeye.se/research/993529/lifecare-target-for-pilot-production-reached?utm_source=finwire&utm_medium=RSS

Nyheter om Lifecare

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!